药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metacycline
Lumacaftor
The serum concentration of Lopinavir can be increased when it is combined with Lumacaftor.
Metacycline
Hygromycin B
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Hygromycin B.
Metacycline
Dihydrostreptomycin
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Dihydrostreptomycin.
Metacycline
Puromycin
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Puromycin.
Metacycline
Neamine
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Neamine.
Metacycline
Apramycin
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Apramycin.
Metacycline
Geneticin
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Geneticin.
Metacycline
Paromomycin
The risk or severity of nephrotoxicity can be increased when Paromomycin is combined with Lopinavir.
Metacycline
Loxoprofen
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Loxoprofen.
Metacycline
Lithium citrate
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Lithium citrate.
Metacycline
Lithium cation
The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Lopinavir.
Metacycline
Dexibuprofen
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Dexibuprofen.
Metacycline
Metamizole
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Metamizole.
Metacycline
Etoricoxib
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Etoricoxib.
Metacycline
Givosiran
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Givosiran.
Metacycline
Tolfenamic acid
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Tolfenamic acid.
Metacycline
Parecoxib
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Parecoxib.
Metacycline
Zomepirac
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Zomepirac.
Metacycline
Nimesulide
The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Nimesulide.
Metacycline
Phenazopyridine
The risk or severity of nephrotoxicity can be increased when Phenazopyridine is combined with Lopinavir.